246 related articles for article (PubMed ID: 26848640)
21. Pleomorphic dermal sarcoma: a more aggressive neoplasm than previously estimated.
Tardío JC; Pinedo F; Aramburu JA; Suárez-Massa D; Pampín A; Requena L; Santonja C
J Cutan Pathol; 2016 Feb; 43(2):101-12. PubMed ID: 26264237
[TBL] [Abstract][Full Text] [Related]
22. A Case of Trichogerminoma With Pilomatrical Differentiation and a Unique Immunohistochemical Profile.
Epperson J; Libow L
Am J Dermatopathol; 2017 Jan; 39(1):e13-e16. PubMed ID: 27898472
[TBL] [Abstract][Full Text] [Related]
23. Atypical fibroxanthoma and pleomorphic dermal sarcoma: A reappraisal.
Cesinaro AM; Gallo G; Tramontozzi S; Migaldi M
J Cutan Pathol; 2021 Feb; 48(2):207-210. PubMed ID: 32583897
[TBL] [Abstract][Full Text] [Related]
24. Foamy cell angiosarcoma is a diagnostic pitfall: a case report of an angiosarcoma mimicking xanthoma.
Svajdler M; Benický M; Fröhlichová L; Beneš T; Hojstričová Z; Kazakov DV
Am J Dermatopathol; 2014 Aug; 36(8):669-72. PubMed ID: 25051043
[TBL] [Abstract][Full Text] [Related]
25. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS).
Helbig D; Ziemer M; Dippel E; Erdmann M; Hillen U; Leiter U; Mentzel T; Osterhoff G; Ugurel S; Utikal J; von Bubnoff D; Weishaupt C; Grabbe S
J Dtsch Dermatol Ges; 2022 Feb; 20(2):235-243. PubMed ID: 35099104
[TBL] [Abstract][Full Text] [Related]
26. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
27. Pleomorphic Dermal Sarcoma: A Clinical and Histopathologic Emulator of Atypical Fibroxanthoma, but Different Biologic Behavior.
Carletti M; Nguyen DA; Malouf P; Ingersoll Z; Hosler GA; Weis SE
HCA Healthc J Med; 2022; 3(5):299-304. PubMed ID: 37425251
[TBL] [Abstract][Full Text] [Related]
28. HMB-45 (gp103) and MART-1 expression within giant cells in an atypical fibroxanthoma: a case report.
Smith-Zagone MJ; Prieto VG; Hayes RA; Timperman WW; Diwan AH
J Cutan Pathol; 2004 Mar; 31(3):284-6. PubMed ID: 14984584
[TBL] [Abstract][Full Text] [Related]
29. Atypical fibroxanthoma--a retrospective immunohistochemical study of 42 cases.
Singh M; Mann R; Ilankovan V; Hussein K; D'arrigo C
J Oral Maxillofac Surg; 2012 Nov; 70(11):2713-8. PubMed ID: 22494510
[TBL] [Abstract][Full Text] [Related]
30. Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a review.
Luzar B; Calonje E
J Cutan Pathol; 2010 Mar; 37(3):301-9. PubMed ID: 19807823
[TBL] [Abstract][Full Text] [Related]
31. Spindle Cell Atypical Fibroxanthoma: Myofibroblastic Differentiation Represents a Diagnostic Pitfall in This Variant of AFX.
Harding-Jackson N; Sangueza M; Mackinnon A; Suster S; Plaza JA
Am J Dermatopathol; 2015 Jul; 37(7):509-14; quiz 515-6. PubMed ID: 26098709
[TBL] [Abstract][Full Text] [Related]
32. Atypical fibroxanthoma-a diagnosis of exclusion!
Tchernev G; Tronnier M; Ananiev J; Taneva T; Patterson JW; Gulubova M; Trafeli JP; Gegova A; Harrell M; Guarneri C; Wollina U; Cardoso JC; Kanazawa N; Zisova L; Forsea AM; Zouboulis CC
Wien Med Wochenschr; 2013 Aug; 163(15-16):380-6. PubMed ID: 23319144
[TBL] [Abstract][Full Text] [Related]
33. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
Buonaccorsi JN; Plaza JA
Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
[TBL] [Abstract][Full Text] [Related]
34. Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma.
Thum C; Husain EA; Mulholland K; Hornick JL; Brenn T
Ann Diagn Pathol; 2013 Dec; 17(6):502-7. PubMed ID: 24080496
[TBL] [Abstract][Full Text] [Related]
35. Recurrent atypical fibroxanthoma with satellite metastasis.
Lee SS; Lewis JM; Liaw K; Bushkell LL; Young YD; Googe PB
J Cutan Pathol; 2015 Jan; 42(1):56-60. PubMed ID: 25407605
[TBL] [Abstract][Full Text] [Related]
36. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
Soleymani T; Tyler Hollmig S
Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
[TBL] [Abstract][Full Text] [Related]
37. Composite Fibrofolliculoma/Trichodiscoma With Vascular Mesenchymal Stromal Overgrowth.
Tran TA; Carlson JA
Am J Dermatopathol; 2016 Jul; 38(7):562-5. PubMed ID: 27322792
[No Abstract] [Full Text] [Related]
38. Peritoneal metastases from an atypical fibroxanthoma.
Lum DJ; King AR
Am J Surg Pathol; 2006 Aug; 30(8):1041-6. PubMed ID: 16861978
[TBL] [Abstract][Full Text] [Related]
39. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
[TBL] [Abstract][Full Text] [Related]
40. Primary intrafascial desmoplastic melanoma with pseudoglandular differentiation and aberrant cytokeratins expression: An exceptional presentation.
Saggini A; Cerroni L; Casini B; Baciorri F; Cota C
Pathol Res Pract; 2019 Dec; 215(12):152668. PubMed ID: 31585813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
